HIV-1 protease-IN-11
HIV-1 protease-IN-11 (compound 34a) is a HIV-1 protease inhibitor with an IC50 of 0.41 nM. HIV-1 protease-IN-11 also exhibits significant activity against drug-resistant variant[1].
Product Specifications
CAS Number
2925287-54-1
UNSPSC
12352005
Target
HIV Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hiv-1-protease-in-11.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(C2=CC=C(C=C2)OC)=O)[C@@H]3CCNC3
Molecular Formula
C26H37N3O5S
Molecular Weight
503.65
References & Citations
[1]Huiyu Zhou, et al. Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant. Eur J Med Chem. 2023 Jul 5;255:115389.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BAF-461-1 1 mL
Biotin Conjugated Goat Affinity Purified Antibody to Rat IgG,
Sign In for Pricing
View Details 
![PerCP/Cyanine5.5 Anti-Mouse CD106 Antibody[M/K-2.7]](https://cdn.genprice.uk/products/763/68dd14ab061270361e7d2c11/imageurl/e-ab-f1091j.webp)
E-AB-F1091J-01 50 Tests
PerCP/Cyanine5.5 Anti-Mouse CD106 Antibody[M/K-2.7]
Sign In for Pricing
View Details